[恩波维铵治疗肠道线虫感染患者的疗效与耐受性]
[Embovin efficacy and tolerance in the treatment of patients with intestinal nematode infections].
作者信息
Dotsenko V A, Markin A V, Tikhomirova E P, Shirinian A A, Petrova T A, Barinova N G, Shiriaeva N P
出版信息
Med Parazitol (Mosk). 1993 Mar-Apr(2):18-9.
The efficacy and tolerance of embovin, a new anthelminthic manufactured in Russia, was studied in 60 patients with nematodiases. The results evidence its high efficacy in ankylostomiasis (100%), enterobiasis (100%), and ascariasis (90 +/- 6.4%). The drug was well tolerated in all the cases. No adverse effects on the liver, pancreas, kidneys, as well as on the peripheral blood and urine composition were detected. This recommends embovin for wide use in medical practice.
对俄罗斯生产的一种新型驱虫药恩波维铵的疗效和耐受性进行了研究，研究对象为60例线虫病患者。结果证明其对钩虫病（100%）、蛲虫病（100%）和蛔虫病（90±6.4%）有很高疗效。在所有病例中该药物耐受性良好。未检测到对肝脏、胰腺、肾脏以及外周血和尿液成分的不良反应。这表明恩波维铵值得在医疗实践中广泛应用。
Zotero 插件